Apellis director restructures 5,750 spouse-held shares
Apellis Pharmaceuticals director Stephanie Monaghan O'Brien reported an internal share restructuring involving her spouse's holdings.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Apellis Pharmaceuticals director Stephanie Monaghan O'Brien reported an internal share restructuring involving her spouse's holdings. A total of 5,750 shares of Common Stock were distributed from a trust to an account held directly by her spouse, and her beneficial ownership is unchanged. Following this, she reports 25,666 shares held directly and 5,750 shares held indirectly through her spouse.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Other | Common Stock | 5,750 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. Represents a distribution of shares from a trust to an account held directly by the reporting person's spouse. The reporting person's beneficial ownership is unchanged.
Key Figures
Key Terms
Common Stock financial
distribution financial
trust financial
beneficial ownership financial
By Spouse financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Apellis (APLS) director Stephanie Monaghan O'Brien report?
Was the Apellis (APLS) Form 4 a buy or sell by Stephanie Monaghan O'Brien?
What does the trust-to-spouse distribution mean for Apellis (APLS) insider ownership?
How is Stephanie Monaghan O'Brien’s indirect ownership in Apellis (APLS) reported?
AI-generated analysis. How Rhea-AI works. Not financial advice.